- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Antibiotics in UTI: GOI Guidelines
A urinary tract infection (UTI) is an infection that affects part of the urinary tract and a common disease encountered by physicians in the course of their work. Correct Prescriptions of Antibiotics ( Antimicrobials) play a very important role in treatment if the disease
In 2016, National Centre For Disease Control , Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India came out with National Treatment Guidelines for Antimicrobial Use in Infectious Diseases.
Following are major recommendation for Urinary Tract Infections:
Condition | Likely Causative Organisms | Empiric antibiotics (presumptive antibiotics) | Alternative antibiotics | Comments |
Acute uncomplicated Cystitis | E.coli, Staphylococcus saphrophyticus(in sexually activeyoungwomen), Klebsiella pneumoniae | Nitrofurantoin 100 mg BD for 7 days or Cotrimoxazole 960mg BD for 3-5 days or Ciprofloxacin 500 mg BD for 3-5 days | Cefuroxime 250 mg BD for 3-5 days | Get urine cultures before antibiotics & modify therapy based on sensitivities. |
Acute uncomplicated Pyelonephritis | E.coli, Staphylococcus saphrophyticus (in sexually active young women), Klebsiella pneumoniae, Proteus mirabilis | Amikacin 1 g OD IM/IV or Gentamicin 7 mg/kg/day OD (Monitor renal function closely and rationalise according to culture report) Complete total duration of 14 days | Piperacillin-Tazobactam 4.5g IV 6 hourly or CefoperazoneSulbactam 3g IV 12 hourly or Ertapenem 1 g IV OD | Urine culture and susceptibilities need to be collected before starting antimicrobial treatment to guide treatment. |
Complicated Pyelonephritis | Escherichia coli, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas aeruginosa, Enterococcus sp. Frequently multi-drug resistant organisms are present | Piperacillin-Tazobactam 4.5gm IV 6 hourly or Amikacin 1 g OD IV or Cefoperazone-Sulbactam 3gm IV 12 hourly | Imipenem 1g IV 8 hourly or Meropenem 1gm IV 8 hourly | Get urine cultures before antibiotics & switch to a narrow spectrum agent based on sensitivities. Treat for 10- 14 days. De-escalate to Ertapenem 1 gm IV OD, if Imipenem/meropenem initiated. Monitor renal function if aminoglycoside is used. |
Acute prostatitis | Enterobacteriaceae (E.coli, Klebsiella sp.) | Doxycline 100 mg BD or Co-trimoxazole 960 mg BD. | In severe cases, Piperacillin-Tazobactam 4.5gm IV 6 hourly or Cefoperazone-sulbactam 3gm IV 12 hourly or Ertapenem 1 gm IV OD or Imipenem 1g IV 8 hourly or Meropenem 1gm IV 8 hourly | Get urine and prostatic massagecultures before antibiotics & switch to narrow spectrum agent based on sensitivities and then treat total for 3-4 weeks. Use Ciprofloxacin (if sensitive) |
Note: Asymptomatic bacteriuria NOT to be treated except pregnant women and immunocompromised patients. All cases of dysuria may not be UTI.
You can read the full Guideline by clicking on the following link :
http://www.ncdc.gov.in/writereaddata/linkimages/AMR_guideline7001495889.pdf
Directorate General of health servicesGovernment of Indiainfectious diseaseMinistry of Health & Family WelfareNational Centre For DiseaseUrinary Tract Infections
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd